HK1221905A1 - 作爲用於炎性腸病和/或腸易激綜合征的治療的應用 - Google Patents

作爲用於炎性腸病和/或腸易激綜合征的治療的應用

Info

Publication number
HK1221905A1
HK1221905A1 HK16110056.2A HK16110056A HK1221905A1 HK 1221905 A1 HK1221905 A1 HK 1221905A1 HK 16110056 A HK16110056 A HK 16110056A HK 1221905 A1 HK1221905 A1 HK 1221905A1
Authority
HK
Hong Kong
Prior art keywords
phy906
treatment
inflammatory bowel
bowel disease
bowel syndrome
Prior art date
Application number
HK16110056.2A
Other languages
English (en)
Inventor
Yung-Chi Cheng
Shwu-Huey Liu
Robert Tilton
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of HK1221905A1 publication Critical patent/HK1221905A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16110056.2A 2007-10-25 2016-08-23 作爲用於炎性腸病和/或腸易激綜合征的治療的應用 HK1221905A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98260807P 2007-10-25 2007-10-25

Publications (1)

Publication Number Publication Date
HK1221905A1 true HK1221905A1 (zh) 2017-06-16

Family

ID=40580082

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11105053.0A HK1150971A1 (en) 2007-10-25 2011-05-23 Use of phy906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome phy906
HK16110056.2A HK1221905A1 (zh) 2007-10-25 2016-08-23 作爲用於炎性腸病和/或腸易激綜合征的治療的應用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK11105053.0A HK1150971A1 (en) 2007-10-25 2011-05-23 Use of phy906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome phy906

Country Status (6)

Country Link
US (4) US20110111070A1 (zh)
EP (2) EP2987495A1 (zh)
JP (3) JP2011500853A (zh)
CN (1) CN101918017B (zh)
HK (2) HK1150971A1 (zh)
WO (1) WO2009055769A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008101079A1 (en) 2007-02-15 2008-08-21 Yale University Herbal-composition phy906 and its use in chemotherapy
MX2012001333A (es) * 2009-07-30 2012-06-01 Teva Pharma Tratamiento de la enfermedad de crohn con la laquinimod.
CN103405527A (zh) * 2013-08-08 2013-11-27 西南大学 改善鸡胃肠功能的中药组合物、提取液及其制剂和应用
JP2023504202A (ja) * 2019-12-09 2023-02-01 イエール ユニバーシティ がんの再発を予防するための組成物および方法
US11701399B2 (en) 2020-02-26 2023-07-18 Industrial Technology Research Institute Composition for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseases, and method for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseases
CN113181252A (zh) * 2021-04-26 2021-07-30 广东省农业科学院动物卫生研究所 黄芩汤在制备治疗腹泻及改善肠道功能药物中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936621A (ja) * 1982-08-25 1984-02-28 Tsumura Juntendo Inc 脂肪分解促進作用阻害剤
JPS6226229A (ja) * 1985-07-26 1987-02-04 Tsumura Juntendo Inc 神経細胞分化促進剤
JPH06172198A (ja) * 1992-12-09 1994-06-21 Sana Seiyaku Kk 動物の下痢予防・抑制剤及び予防・抑制方法
US5563133A (en) * 1995-02-21 1996-10-08 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
US6048847A (en) * 1997-09-30 2000-04-11 Dabur Research Foundation Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
JP5054863B2 (ja) * 1997-11-04 2012-10-24 帝國製薬株式会社 潰瘍性大腸炎治療剤
HUP0102782A3 (en) * 1998-06-19 2002-12-28 Smithkline Beecham Corp Salycilanilide as inhibitors of transcription factor nf-kb
USRE37262E1 (en) * 1998-11-02 2001-07-03 Chinese Medicines Scientific Consultants Pty. Ltd. Herbal compositions for treatment of gastrointestinal disorders
US6630176B2 (en) * 2000-03-07 2003-10-07 Mount Sinai School Of Medicine Of New York University Herbal remedies for treating allergies and asthma
US7534455B2 (en) * 2000-03-09 2009-05-19 Yale University Herbal composition PHY906 and its use in chemotherapy
AU4550801A (en) 2000-03-09 2001-09-17 Univ Yale Herbal composition phy906 and its use in chemotheraphy
WO2008101079A1 (en) 2007-02-15 2008-08-21 Yale University Herbal-composition phy906 and its use in chemotherapy
WO2009152228A2 (en) 2008-06-10 2009-12-17 Yale University Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen
CN1168460C (zh) * 2001-08-13 2004-09-29 姜良铎 一种具有调节胃肠功能作用的中药保健品
KR20020037736A (ko) * 2002-04-29 2002-05-22 박정근 변비(便秘) 조제 형성법
CN1250255C (zh) * 2003-01-28 2006-04-12 南京师范大学 治疗肠功能紊乱疾病的中药组合物及其制剂
AU2004229462A1 (en) * 2003-04-08 2004-10-28 Progenics Pharmaceuticals, Inc. The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
US20050113365A1 (en) * 2003-11-10 2005-05-26 Sir Isaac Newton Enterprises Llc Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome
CN100341487C (zh) * 2005-01-31 2007-10-10 北京正大绿洲医药科技有限公司 一种用于消炎的双黄消炎滴丸
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders

Also Published As

Publication number Publication date
JP2011500853A (ja) 2011-01-06
US11452755B2 (en) 2022-09-27
US20210106643A1 (en) 2021-04-15
US20190117720A1 (en) 2019-04-25
JP2014058570A (ja) 2014-04-03
US10849951B2 (en) 2020-12-01
EP2214496A4 (en) 2012-06-06
CN101918017A (zh) 2010-12-15
HK1150971A1 (en) 2012-01-20
EP2987495A1 (en) 2016-02-24
US10058581B2 (en) 2018-08-28
CN101918017B (zh) 2013-07-31
US20150182575A1 (en) 2015-07-02
US20110111070A1 (en) 2011-05-12
WO2009055769A1 (en) 2009-04-30
JP2016029116A (ja) 2016-03-03
EP2214496A1 (en) 2010-08-11

Similar Documents

Publication Publication Date Title
ZA201100974B (en) Treatment of autoimmune and inflammatory disease
HK1221905A1 (zh) 作爲用於炎性腸病和/或腸易激綜合征的治療的應用
IL225519A0 (en) Effective preparations and methods for the treatment and diagnosis of inflammatory bowel disease
GB2450974B (en) Treatment of inflammatory bowel disease with cannabinoids
HRP20190045T1 (hr) Metode i sastavi za liječenje upalne bolesti crijeva
HK1131047A1 (en) Treatment of inflammatory diseases
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
HK1139860A1 (en) Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
GB0718446D0 (en) Compositions and methods for the treatment of infection
ZA200801678B (en) Treatment of inflammatory bowel disease
GB0700972D0 (en) Treatment of inflammatory disease
ZA201102442B (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
EP2056858A4 (en) TREATMENT OF PULMONARY DISEASE CONDITIONS
IL255052A0 (en) Treatment of inflammatory bowel diseases by 6-mercaptopurine
GB0720976D0 (en) Treatment of inflammatory disease
EP2099488A4 (en) TSLP VACCINE FOR THE TREATMENT OF TH2-INDUCED INFLAMMATORY DISORDERS
BRPI1008259A2 (pt) composição para prevenção ou tratamento de síndrome do intestino irritável
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
IL193686A0 (en) Agent for prevention/treatment of irritable bowel syndrome
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
GB0712390D0 (en) Use of compounds in the treatment of pain and irritable bowel syndrome
GB0705424D0 (en) Use of compounds in the treatment of pain and irritable bowel syndrome
AU2008902215A0 (en) Methods of diagnosis and treatment of inflammatory bowel disease
GB0618309D0 (en) Compositions and methods for the treatment of disease
EP2276502A4 (en) COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF NEUROLOGICAL INJURIES AND ASSOCIATED METHODS OF USE